GSA: Behavioral, histological, electrophysiological and neurochemical effects

Physiology and Behavior

Volumn 84, Issue 2, 2005, Pages 251-264

  Torremans, An ^a   Marescau, Bart ^a   Van Dam, Debby ^a   Van Ginneken, Chris ^b   Van Meir, Frans ^b   Van Bogaert, Pierre Paul ^a   D'Hooge, Rudi ^a   De Vente, Jan ^c   De Deyn, Peter Paul ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b UNIVERSITY OF ANTWERP   (Belgium)

^c MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Animal model; Behavior; Guanidino compounds; Guanidinosuccinic acid (GSA); Neurotoxin; Renal failure; Uremia

Indexed keywords

2 AMINO 4 METHYL 5 PHOSPHONO 3 PENTENOIC ACID; GUANIDINOSUCCINIC ACID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR; BRAIN SIZE; COGNITION; DRUG EFFECT; ELECTROPHYSIOLOGY; EXPLORATORY BEHAVIOR; HIPPOCAMPUS; HISTOLOGY; IN VIVO STUDY; MOUSE; NEUROCHEMISTRY; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTECTION; SOCIAL BEHAVIOR; SPINAL CORD NERVE CELL;

EID: 13544275561     PISSN: 00319384     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.physbeh.2004.12.001     Document Type: Article

References (65)

1. R. Brouns, and P.P. De Deyn Neurological complications in renal failure: a review Clin. Neurol. Neurosurg. 107 2004 1 16
2. P. Scarpelli, F. De Cesaris, and A. Becucci Brain atrophy in uremia: its underevaluated meaning and consequences Nephron 90 2002 510
3. G. Savazzi, and F. Cusmano Brain atrophy in uremia. Research of the causes and future perspectives Nephron 92 2002 748
4. R. Vanholder Uremic toxins Adv. Nephrol. 26 1997 143 162
5. R. Vanholder, and R. De Smet Pathophysiologic effects of uremic retention solutes J. Am. Soc. Nephrol. 10 1999 1815 1823
6. R. Vanholder, A. Argiles, U. Baurmeister, P. Brunet, W. Clark, and G. Cohen Uremic toxicity: present state of the art Int. J. Artif. Organs 24 2001 695 725
7. T. Hanai, Y. Inamaoto, and S. Inamoto Chromatography of guanidino compounds J. Chromatogr., B, Biomed. Sci. Appl. 747 2000 123 138
8. W. Horl Uremic toxins: new aspects J. Nephrol. 13 Suppl. 3 2000 S83 S88
9. P.P. De Deyn, B. Marescau, J. Cuykens, L. Van Gorp, A. Lowenthal, and W. De Potter Guanidino compounds in serum and cerebrospinal fluid of non-dialysed patients with renal insufficiency Clin. Chim. Acta 167 1987 81 88
10. P.P. De Deyn, and R. Macdonald Guanidino compounds that are increased in cerebrospinal fluid and brain of uremic patients inhibit GABA and Glycine response on mouse neurons in cell culture Ann. Neurol. 28 1990 627 633
11. P.P. De Deyn, B. Marescau, R. D'Hooge, I. Possemiers, J. Nagler, and C. Mahler Guanidino compound levels in brain regions of non-dialyzed uremic patients Neurochem. Int. 27 1995 227 237
12. P.P. De Deyn, R. D'Hooge, P. Van Bogaert, and B. Marescau Endogenous guanidino compounds as uremic neurotoxins Kidney Int. 59 Suppl. 78 2001 S77 S83
13. M. Al Banchaabouchi, B. Marescau, R. D'Hooge, E. Van Marck, A. Van Daele, and O. Levillain Biochemical and histopathological changes in nephrectomized mice Metabolism 47 1998 336 355
14. R. D'Hooge, A. Raes, P. Lebrun, M. Diltoer, P. Van Bogaert, and J. Manil N-methyl-d-aspartate receptor activation by guanidinosuccinate but not by methylguanidine: behavioral and electrophysiological evidence Neuropharmacology 35 1996 433 440
15. R. D'Hooge, P.P. De Deyn, G. Van de Vijver, G. Antoons, A. Raes, and P.P. Van Bogaert Uraemic guanidino compounds inhibit gamma-aminobutyric acid-evoked currents in mouse spinal cord neurones Neurosci. Lett. 265 1999 83 86
16. 2+ channels in the neuroexcitatory and synergistic effects of putative uremic neurotoxins Kidney Int. 63 2003 1764 1775
17. P. Vallance Nitric oxide Biologist 48 2001 153 158
18. R. D'Hooge, Y. Pei, and P.P. De Deyn N-methyl-d-aspartate receptors contribute to guanidinosuccinate-induced convulsions in mice Neurosci. Lett. 157 1993 123 126
19. J. Pan, Y. Pei, L. An, and L. Lai Epileptiform activity and hippocampal damage produced by intrahippocampal injection of guanidinosuccinic acid in rat Neurosci. Lett. 209 1996 121 124
20. G. Souheaver, J. Ryan, and A. DeWolfe Neuropsychological patterns in uremia J. Clin. Psychol. 38 1982 490 496
21. S. Evers, M. Tepel, M. Obladen, B. Suhr, I. Husstedt, and K. Grotemeyer Influence of end-stage renal failure and hemodialysis on event-related potentials J. Clin. Neurophysiol. 15 1998 58 63
22. N.R. Carlson Physiology of behavior: learning and memory: basic mechanims 6th ed. 1998 Allyn and Bacon Boston
23. H. Rang, M. Dale, and J. Ritter Pharmacology: the central nervous system 4th ed. 1999 Churchill Livingstone Edinburgh
24. L. Squire Memory and the hippocampus: a synthesis from findings with rats, monkeys and humans Psychol. Rev. 99 1992 195 231
25. R. Morris, E. Anderson, G. Lynch, and M. Baudry Selective impairment of learning and blockade of long-term potentiation by an N-methyl-d-aspartate receptor antagonist, AP5 Nature 319 1996 774 776
26. N. Burgess, E. Maguire, and J. O'Keefe The human hippocampus and spatial and episodic memory Neuron 35 2002 625 641
27. K. Franklin, and G. Paxinos The mouse brain in stereotaxic coordinates 1997 Academic Press California
28. J. Crawley, and F. Goodwin Preliminary report of a simple animal behavior model for the anxiolytic effects of benzodiazepines Pharmacol. Biochem. Behav. 13 1980 167 170
29. R. Morris Developments of a water-maze procedure for studying spatial learning in the rat J. Neurosci. Methods 11 1984 47 60
30. R. D'Hooge, and P.P. De Deyn Applications of the Morris water maze in the study of learning and memory Brain Res. Rev. 36 2001 60 90
31. N. Dunham, and T. Miya A note on a simple apparatus for detecting neurological deficit in rats and mice J. Am. Pharm. Assoc. Am. Pharm. Assoc. 46 1957 208 209
32. B. Cavalieri Geometria degli Indivisibili 1966 Unione Tipografico-Editrice Torinese Torino
33. A. Steiner, C. Parker, and D. Kipnis Radioimmunoassay for cyclic nucleotides J. Biol. Chem. 274 1972 1106 1113
34. O. Lowry, N. Rosebrough, A. Farr, and F. Randall Protein measurements with the Folin reagent J. Biol. Chem. 193 1951 265 275
35. B. Ransom, P. Bullock, and P. Nelson Mouse spinal cord in cell culture III. Neuronal chemosensitivity and its relationship to synaptic activity J. Neurophysiol. 40 1977 1163 1170
36. R. Deacon, D. Bannerman, B. Kirby, A. Croucher, and J. Rawlins Effects of cytotoxic hippocampal lesions in mice on a cognitive test battery Behav. Brain Res. 133 2002 57 68
37. D. Bannerman, B. Yee, M. Good, M. Heupel, S. Iversen, and J. Rawlins Double dissociation of function within the hippocampus: a comparison of dorsal, ventral, and complete hippocampal cytotoxic lesions Behav. Neurosci. 113 1999 1170 1188
38. D. Bannerman, M. Lameire, S. Beggs, J. Rawlin, and S. Iversen Cytotoxic lesions of the hippocampus increase social investigation but do not impair social-recognition memory Exp. Brain Res. 138 2001 100 109
39. T. Murray, and R. Ridley The effect of excitotoxic hippocampal lesions on simple and conditional discrimination learning in the rat Behav. Brain Res. 99 1999 103 113
40. R. Feldman, J. Meyer, and L. Quenzer Principles of neuropsychopharmacology: the amino acid neurotransmitters and histamine 1997 Sinauer Associates Massachusetts
41. D. Sherry, L. Jacobs, and S. Gaulin Spatial memory and adaptive specialization of the hippocampus Trends Neurosci. 15 1992 298 303
42. T. Smulders, A. Sasson, and T. De Voogd Seasonal variation in hippocampal volume in a food-storing bird, the black-capped chickadee J. Neurobiol. 27 1995 15 25
43. W. Zhang, T. Bast, and J. Feldon Effects of hippocampal N-methyl-d-aspartate infusion on locomotor activity and prepulse inhibition: differences between the dorsal and ventral hippocampus Behav. Neurosci. 116 2002 72 84
44. E. Coutureau, R. Galani, L. Jarrard, and J. Cassel Selective lesions of the entorhinal cortex, the hippocampus, or the fimbria-fornix in rats: a comparison of effects on spontaneous and amphetamine-induced locomotion Exp. Brain Res. 131 2000 381 392
45. R. Deacon, A. Croucher, and J. Rawlins Hippocampal cytotoxic lesion effects on species-typical behaviors in mice Behav. Brain Res. 132 2002 203 213
46. A. Mohn, R. Gainetdinov, M. Caron, and B. Koller Mice with reduced NMDA receptor expression display behaviors related to schizophrenia Cell 98 1999 427 436
47. F. Sams-Dodd, B. Lipska, and D. Weinberger Neonatal lesions of the rat ventral hippocampus result in hyperlocomotion and deficits in social behavior in adulthood Psychopharmacology 132 1997 303 310
48. R. Deacon, D. Bannerman, and J. Rawlins Anxiolytic effects of cytotoxic hippocampal lesions in rats Behav. Neurosci. 116 2002 494 497
49. A. Contestabile, P. Migani, A. Poli, and L. Villani Recent advances in the use of selective neuron-destroying agents for neurobiological research Experientia 40 1984 524 534
50. M. Rogawski, D. Gryder, D. Casteneda, W. Yonekawa, M. Banks, and H. Lia GluR5 kainate receptors, seizures, and the amygdala Ann. N.Y. Acad. Sci. 985 2003 150 162
51. B. Meldrum Excitotoxicity and epileptic brain damage Epilepsy Res. 10 1991 55 61
52. R. Kalviainen, and T. Salmenpera Do recurrent seizures cause neuronal damage? A series of studies with MRI volumetry in adults with partial epilepsy Prog. Brain Res. 135 2002 279 295
53. I. Reid, and C. Stewart Seizures, memory and synaptic plasticity Seizure 6 1997 651 659
54. Y. Sogawa, M. Monokoshi, D. Silveira, B. Cha, M. Cilio, and B. McCabe Timing of cognitive deficits following neonatal seizures: relationship to histological changes in the hippocampus Brain Res. Dev. Brain Res. 131 2001 73 83
55. S. Gutnikov, and J. Rawlins Systemic NMDA antagonist CGP-37849 produces non-specific impairment in a working memory task: the effect does not resemble those of AP5 and of lesions of the hippocampus or fornix Neuropsychologia 34 1996 311 314
56. M. Misztal, and W. Danysz Comparison of glutamate antagonists in continuous multiple-trial and single-trial dark avoidance Behav. Pharmacol. 6 1995 550 561
57. C. Bischoff, and P. Tiedtke Competitive and non-competitive NMDA-receptor antagonists in spatial learning tasks Eur. J. Pharmacol. 213 1992 269 273
58. R. D'Hooge, Y. Pei, B. Marescau, and P.P. De Deyn Behavioral toxicity of guanidinosuccinic acid in adult and young mice Toxicol. Lett. 773 1992 64 65
59. S. Archer Measurement of nitric oxide in biological models FASEB J. 7 1993 349 360
60. U. Förstermann, and K. Ishii M. Feelisch J.S. Stamler Methods in nitric oxide research: measurement of cyclic GMP as an indicator of nitric oxide production 1996 John Wiley & Sons New York
61. H. Yasuda, M. Fujii, H. Fujisawa, H. Ito, and M. Suzuki Changes in nitric oxide synthesis and epileptic activity in the contralateral hippocampus of rats following intrahippocampal kainate injection Epilepsia 42 2001 13 20
62. P. Wood, M. Emmett, T. Rao, J. Cler, S. Mick, and S. Iyengar Inhibition of nitric oxide synthase blocks N-metyl-d-aspartate-, quisqualate-, kainate-, harmaline-, and pentylenetetrazole-dependent increases in cerebellar cyclic GMP in vivo J. Neurochem. 55 1990 346 348
63. C. Montoliu, M. Llansola, P. Monfort, R. Corbalan, and I. Fernandez-Marticorena Role of nitric oxide and cyclic GMP in glutamate-induced neuronal death Neurotox. Res. 3 2001 179 188
64. D. Milatovic, R. Gupta, and W. Dettbarn Involvement of nitric oxide in kainic acid-induced excitotoxicity in rat brain Brain Res. 957 2002 330 337
65. R. D'Hooge, A. Raes, P. Van Bogaert, M. Geelhand, and P.P. De Deyn Selective block of N-methyl-d-aspartic acid (NMDA)-evoked whole-cell currents in mouse cultured spinal neurones by CGP40116 Br. J. Pharmacol. 120 1997 211 214